Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Gepotidacin: Reading Evidence Beyond the Mechanism
2026-10-07
Gepotidacin, also known as GSK2140944, represents a distinct bacterial topoisomerase strategy for antibacterial research. This article interprets its biochemical rationale, phase 2 gonorrhea evidence, resistance signals, and limitations without reducing translational science to a laboratory protocol.
-
Endothelial SGK1 and Vascular Stiffening
2026-10-06
Zhang and colleagues identify endothelial SGK1 as a mechanistic link between mineralocorticoid–salt exposure, endothelial sodium-channel activity, actin remodeling, and vascular stiffening. By combining endothelial-specific genetics, a DOCA–salt mouse model, and human aortic endothelial-cell experiments, the study strengthens the case for SGK1 as a target for mechanistic hypertension research while defining important limits on pharmacological interpretation.
-
Isochlorogenic Acid A Hydrogel: Study Evidence
2026-10-05
A 2026 Gels study reported a multifunctional wound dressing that combines Isochlorogenic acid A/Fe(III) co-assembled nanoparticles with an amylopectin–carboxymethyl chitosan hydrogel. The preclinical formulation showed antibacterial activity, favorable material properties, enhanced cell migration, and improved wound-repair-associated outcomes, while remaining subject to important limitations in model scope and clinical applicability.
-
Cytochalasin D: Evidence, Scope and Limits
2026-10-04
A source-grounded overview of Cytochalasin D as an actin polymerization inhibitor, using a human corneal epithelial nanoparticle-uptake study to clarify mechanistic interpretation, evidence quality, applicability and limitations.
-
Alfuzosin HCl: From Receptor Biology to Translation
2026-10-03
A source-grounded perspective on how Alfuzosin HCl connects α1-receptor pharmacology, lower urinary tract physiology, analytical validation, and translational study design—while distinguishing assay performance from clinical evidence.
-
ISRIB and the Biology of Accelerated Forgetting
2026-10-01
ISRIB (trans-isomer) offers translational researchers a mechanistically grounded way to interrogate how integrated stress response signaling influences inflammation-associated memory loss. By connecting PERK–eIF2α–ATF4 biology with hippocampal forgetting, this article outlines an evidence-led strategy for ER stress research, apoptosis assay design, and neurodegenerative disease model development.
-
Adiponectin, TLR4, and Cognitive Deficits in Aged Rats
2026-10-01
This reference study examines how adiponectin protects aged rats from splenectomy-associated cognitive impairment, linking improved Morris water maze performance to reduced TLR4/MyD88/NF-κB signaling, oxidative stress, and microglial inflammation. Its pharmacological comparison with TAK-242 and LPS strengthens the proposed pathway model while also highlighting the limits of translating adiponectin findings to other peptide hormones or cardiovascular systems.
-
GPNMB Model Predicts ESCC Immunotherapy Response
2026-10-01
This study identifies circulating soluble GPNMB as both a mechanistically active mediator of CD8+ T-cell exhaustion and a biomarker of resistance to PD-1 blockade in esophageal squamous cell carcinoma. By integrating plasma GPNMB, CAF-Epi niche features, and clinicopathological variables, the authors develop a multimodal framework with potential value for response prediction and translational patient stratification.
-
Amikacin Sulfate: NTM Workflow Guide
2026-09-30
Build more informative NTM experiments by separating extracellular killing, intracellular activity, and granuloma-targeted delivery. This practical Amikacin guide combines concentration-aware assays, dendritic-cell uptake workflows, controls, and troubleshooting for translational research.
-
GW 4869: N-SMase and Exosome Research
2026-09-29
GW 4869 hydrochloride hydrate is a cell-permeable, noncompetitive neutral sphingomyelinase inhibitor and sphingolipid metabolism modulator. It is widely used as an inhibitor of exosome biogenesis, but inhibitor-based reductions in extracellular vesicle signaling require viability, particle, and cargo controls.
-
TAK-242 (Resatorvid) for TLR4 Inflammation
2026-09-29
TAK-242 (Resatorvid) enables selective interrogation of TLR4-dependent inflammation in macrophage, neuronal, and neuroinflammation models. This guide translates the reference study into practical assay design, pathway controls, optimization steps, and troubleshooting strategies.
-
Anlotinib and Angiogenic Kinase Signaling
2026-09-28
The reference study shows that anlotinib suppresses VEGF-, PDGF-BB-, and FGF-2-driven angiogenesis by inhibiting VEGFR2, PDGFRβ, FGFR1, and their downstream ERK signaling. Its combined migration, tube formation, ex vivo vessel-sprouting, and CAM experiments provide a useful preclinical framework for studying multi-pathway angiogenesis inhibition.
-
Baricitinib in PSC: From Maps to Causality
2026-09-28
Baricitinib (LY3009104) offers a JAK1/2 perturbation tool for testing inflammatory signaling suggested by spatial studies of primary sclerosing cholangitis. This article focuses on what spatial proteomics can—and cannot—establish, and how to interpret follow-up experiments without confusing pathway inhibition with disease proof.
-
Sodium Ascorbate: ROS Research Evidence & Use
2026-09-27
Sodium Ascorbate is a mineral salt of ascorbic acid used in preclinical redox and oncology research. Product-reported findings in glioblastoma and prostate cancer models support further experimental study, not clinical efficacy; the product listing’s water-solubility statement also warrants verification before preparing aqueous stocks.
-
APEX2 Supports TERT Expression in Human Stem Cells
2026-09-26
A 2024 bioRxiv preprint reports that APEX2, unlike its paralog APEX1, is required for efficient TERT expression and telomerase activity in human embryonic stem cells. RNA-seq and chromatin immunoprecipitation results point to repetitive DNA regions, especially MIR sequences within TERT, as possible links between APEX2-dependent DNA repair and gene expression.